EligibleTrials

NOPE37: Angiogenic Factors for Managing Term Preeclampsia

Recruiting · NCT07193680 · Interventional (participants receive a specific treatment) · Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Intervention arm: expectant management if sFlt-1/PlGF<38Standard care: elective delivery at 37 weeks of gestation

What this trial is about

This study tests the hypothesis that, in women with preeclampsia without severe features, delivery management based on sFlt-1/PlGF would reduce the rate of induction of labor without worsening the rate of progression to preeclampsia with severe features and other maternal complications.

Who can take part

Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

23 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.